Cargando…
Neuroexcitatory effects of morphine-3-glucuronide are dependent on Toll-like receptor 4 signaling
BACKGROUND: Multiple adverse events are associated with the use of morphine for the treatment of chronic non-cancer pain, including opioid-induced hyperalgesia (OIH). Mechanisms of OIH are independent of opioid tolerance and may involve the morphine metabolite morphine-3-glucuronide (M3G). M3G exhib...
Autores principales: | Due, Michael R, Piekarz, Andrew D, Wilson, Natalie, Feldman, Polina, Ripsch, Matthew S, Chavez, Sherry, Yin, Hang, Khanna, Rajesh, White, Fletcher A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519737/ https://www.ncbi.nlm.nih.gov/pubmed/22898544 http://dx.doi.org/10.1186/1742-2094-9-200 |
Ejemplares similares
-
Decoy peptide targeted to Toll-IL-1R domain inhibits LPS and TLR4-active metabolite morphine-3 glucuronide sensitization of sensory neurons
por: Allette, Yohance M., et al.
Publicado: (2017) -
The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain
por: Feldman, Polina, et al.
Publicado: (2012) -
Carbamazepine Potentiates the Effectiveness of Morphine in a Rodent Model of Neuropathic Pain
por: Due, Michael R., et al.
Publicado: (2014) -
Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide
por: de Hoogd, Sjoerd, et al.
Publicado: (2017) -
Pharmacokinetics of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Terminally Ill Adult Patients
por: Franken, Linda G., et al.
Publicado: (2015)